An Observational Study of Skin Reaction in Infants Using the Owlet Sock OSS 3.0
NCT ID: NCT05561946
Last Updated: 2022-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2021-12-21
2022-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A review of the medical record will be performed with the consent process to ensure that vital signs and the cardiorespiratory status of the patient is sufficiently stable for the patient to proceed with study participation. A verbal medical history from the parent may be performed in lieu of a medical record review in healthy subjects.
Subject height and weight, and measurements of the circumference of the subject's ankle and midfoot will be performed at the start of the study and recorded. Sock size will be estimated according to subject weight, per the instructions for use.
The device will be worn by the subject continuously, except during skin assessments, when devices are exchanged, or activities of daily living such as bathing and brief ambulation for toddlers.
A baseline photograph will be taken of the study subject's feet and labeled as right/left, to be kept for reference for future skin exams. Skin examinations will be performed every 4 hours on the foot where the device is placed, including with repositioning. A ±30-minute window on either side of the prescribed time will be acceptable (1 hour total) to comply with the schedule of events.
Repositioning the device to the opposite foot will occur routinely every 8 hours, or sooner if there is evidence of a skin reaction related to device wear. Again, a ±30-minute window on either side of the prescribed time will be acceptable for protocol compliance.
A photograph will be taken of the study subject's feet at baseline prior to application of the Owlet Sock OSS 3.0 device. A photograph of the initial application of the device will also be taken and documented in the study subject's record.
Documentation of the date, time, location, and result of each skin exam will be performed. Photographs of any skin reactions with a severity level of 1-7 will be taken. If any skin reactions are observed, the device will not be placed on the affected foot until the reaction has resolved and returned to baseline. The device will be applied to the unaffected foot while the affected foot reaction resolves. If the skin finding does not resolve within the allowed 8 hour window when the sock must be rotated to the opposite foot, the subject will be withdrawn from study intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized Infants
Hospitalized infants that are planned/scheduled to remain in-house for at least 2 days will wear the sock for a minimum of 48 hours and a maximum of 14 days.
Owlet OSS 3.0
The Owlet OSS 3.0 is worn continuously for a minimum of 48 hours and the skin where the device is worn is monitored for any skin injury/irritation
Healthy Infants
Healthy infants, accompanied by their parent or legal guardian, that are able to stay at a clinical site for 2 days to complete a minimum of 48 hours of monitoring.
Owlet OSS 3.0
The Owlet OSS 3.0 is worn continuously for a minimum of 48 hours and the skin where the device is worn is monitored for any skin injury/irritation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Owlet OSS 3.0
The Owlet OSS 3.0 is worn continuously for a minimum of 48 hours and the skin where the device is worn is monitored for any skin injury/irritation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness of the guardian to adhere to study procedures and availability for the duration of the study
* Anticipated to maintain continuity of study procedures under study team oversight for a minimum of 48 hours duration
* Male or female infants aged 1 month (44 weeks corrected gestational age) to 18 months, with weight between 5 and 30 lbs who will be observed in a hospital pediatric department, or other clinical site
Exclusion Criteria
* Presence of any devices or medical equipment that in the opinion of the investigator would interfere with the function of the Owlet device or preclude completion of the protocol
* Patients on vasoactive medications
* Known allergic reactions to nylon, spandex, elastine or polyester film components of the device that will come into contact with skin
* Local skin disease prohibiting wearing of the device
44 Weeks
18 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Louisiana State University Health Sciences Center Shreveport
OTHER
University of Utah
OTHER
Topaz Clinical Research
UNKNOWN
Owlet Baby Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alisa Niksch, MD
Role: STUDY_DIRECTOR
Study Sponsor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TOPAZ Clinical Research
Apopka, Florida, United States
Louisiana State University Health Shreveport
Shreveport, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
World Health Organization. MHealth: New Horizons for Health through Mobile Technologies (Global Observatory for Ehealth). 1st ed., World Health Organization, 2011.
Dangerfield MI, Ward K, Davidson L, Adamian M. Initial Experience and Usage Patterns With the Owlet Smart Sock Monitor in 47,495 Newborns. Glob Pediatr Health. 2017 Dec 4;4:2333794X17742751. doi: 10.1177/2333794X17742751. eCollection 2017.
Panda SS, Panda M, Das RR, Mohanty PK. Pulse oximeter probe-induced toe injury in a neonate: A rare avoidable injury. J Clin Neonatol 2014;3:240
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OWL 2021-01
Identifier Type: -
Identifier Source: org_study_id